Optimizing treatment for patients with metastatic renal cell carcinoma in the central and Eastern European region

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F12%3A12916" target="_blank" >RIV/00216208:11110/12:12916 - isvavai.cz</a>

Alternative codes found

RIV/00064165:_____/12:12916

Result on the web

<a href="http://dx.doi.org/10.1517/14656566.2012.647406" target="_blank" >http://dx.doi.org/10.1517/14656566.2012.647406</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Optimizing treatment for patients with metastatic renal cell carcinoma in the central and Eastern European region

Original language description

Belarus, Bulgaria, Croatia, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Republic of Moldova, Romania, Russian Federation, Serbia, Slovakia, Slovenia and the Ukraine represent a collection of Central and Eastern European (CEE) countries in which the epidemiology and treatment of cancer varies greatly between and within countries. Current challenges include non-adherence to current treatment guidelines, restrictions in access and reimbursement for new therapies, and a lack of basic oncology programs. Metastatic renal cell carcinoma (mRCC) is a malignancy with historically poor prognosis. In CEE countries, the incidence and mortality rates of mRCC are among the highest in the world. Fortunately, mRCC represents a cancer for which a numberof new targeted therapies have recently demonstrated benefit, resulting in new evidence-based treatment guidelines. Incorporating these mRCC treatment recommendations into the routine care of patients with mRCC in CEE countries would rep

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FR - Pharmacology and apothecary chemistry

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2012

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Expert Opinion on Pharmacotherapy

ISSN

1465-6566

e-ISSN

—

Volume of the periodical

13

Issue of the periodical within the volume

2

Country of publishing house

GB - UNITED KINGDOM

Number of pages

16

Pages from-to

159-174

UT code for WoS article

000299091900002

EID of the result in the Scopus database

—